Learning Lab

What AI Can (and Can't) Do for Home Infusion

Every vendor says AI will transform your workflow. Most of it won’t. Trey Holterman, Tennr CEO and co-founder, will break down where AI is actually moving patients through intake, qualification, and payer requirements, and where it isn’t. This session will tell you how to separate technology that sounds impressive from technology that actually drives intelligent patient routing.
Every vendor says AI will transform your workflow. Most of it won't. Trey Holterman, Tennr CEO and co-founder, will break down where AI is actually moving patients through intake, qualification, and payer requirements, and where it isn't. This session will tell you how to separate technology that sounds impressive from technology that actually drives intelligent patient routing.

Learning Objectives

  • How AI surfaces the bottlenecks that quietly kill throughput before patients fall off the path to therapy
  • The gap in patient orchestration and care that off-the-shelf LLM solutions haven’t focused on solving
  • How to evaluate emerging technology on what actually matters: patient movement, business performance, and care access
  • Speaker(s)

    Jonathan Bridges 


    Trey Holterman  CEO
    Tennr

                array(6) {
      [0]=>
      string(17) "Session Organizer"
      [1]=>
      string(19) "Symposium Organizer"
      [2]=>
      string(22) "Learning Lab Organizer"
      [3]=>
      string(13) "ISC Organizer"
      [4]=>
      string(16) "Industry Contact"
      [5]=>
      string(17) "Theater Organizer"
    }
                

    Share: